NZ192927A - Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions - Google Patents

Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions

Info

Publication number: NZ192927A
Authority: NZ; New Zealand
Prior art keywords: isopropylamino; pyrimidine; pharmaceutical compositions; hydroxy derivatives; hydroxy
Prior art date: 1979-03-10

Application number

NZ192927A

Other languages

English (en)

Inventor

A Esanu

Original Assignee

Soc D Etudes Prod Chimique

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-10

Filing date

1980-02-20

Publication date

1981-07-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ192927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1980-02-20 Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique

1981-07-13 Publication of NZ192927A publication Critical patent/NZ192927A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NZ192927A 1979-03-10 1980-02-20 Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions NZ192927A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB7908494		1979-03-10
GB7914987		1979-04-30

Publications (1)

Publication Number	Publication Date
NZ192927A true NZ192927A (en)	1981-07-13

Family

ID=26270867

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NZ192927A NZ192927A (en)	1979-03-10	1980-02-20	Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions

Country Status (24)

Country	Link
JP (1)	JPS55122768A (no)
AR (1)	AR222691A1 (no)
AU (1)	AU533547B2 (no)
BE (1)	BE881752A (no)
CA (1)	CA1132561A (no)
CH (1)	CH644368A5 (no)
DE (3)	DE3009071C2 (no)
EG (1)	EG14282A (no)
FI (1)	FI66357C (no)
FR (2)	FR2451191A1 (no)
GB (1)	GB2045756B (no)
HK (1)	HK55383A (no)
IE (1)	IE49547B1 (no)
IN (1)	IN153791B (no)
LU (1)	LU82185A1 (no)
MX (1)	MX6218E (no)
MY (1)	MY8400200A (no)
NL (1)	NL184833C (no)
NO (1)	NO154054C (no)
NZ (1)	NZ192927A (no)
OA (1)	OA06484A (no)
PT (1)	PT70882A (no)
SE (1)	SE435180B (no)
SG (1)	SG22683G (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE894517A (fr) *	1981-10-16	1983-01-17	Sod Conseils Rech Applic	Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) *	1983-10-03	1985-11-19	Pfizer Inc.	2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) *	1983-10-03	1987-06-16	Pfizer Inc.	Method for treatment of gastrointestinal disorders
US4711888A (en)	1985-07-24	1987-12-08	Pfizer Inc.	Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) *	1987-07-09	1989-01-26	Pfizer Inc.	2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) *	1988-06-28	1990-03-20	Pfizer Inc.	2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) *	1988-12-29	1993-11-23	Mitsui Petrochemical Industries, Ltd.	Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) *	1988-12-29	1992-10-28	Mitsui Petrochemical Ind	Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) *	1989-05-26	1990-07-10	Pfizer Inc.	Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) *	1991-09-09	1993-12-14	Warner-Lambert Company	5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5196431A (en) *	1992-02-24	1993-03-23	Warner-Lambert Company	2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5220025A (en) *	1992-02-24	1993-06-15	Warner-Lambert Company	2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) *	2005-06-15	2015-09-15	Vanderbilt University	Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB741667A (en) *	1952-12-05	1955-12-07	Ici Ltd	New pyrimidine derivatives
GB756189A (en) *	1954-02-01	1956-08-29	Ici Ltd	New pyrimidine derivatives
ZA711152B (en) *	1970-03-02	1971-11-24	Ici Ltd	Manufacture of pyrimidines
GB1525995A (en) *	1976-02-18	1978-09-27	Soc D Etudes Prod Chimique	Aminopyrimidine salt

1980
- 1980-02-12 IN IN103/DEL/80A patent/IN153791B/en unknown
- 1980-02-15 BE BE0/199421A patent/BE881752A/fr not_active IP Right Cessation
- 1980-02-20 NZ NZ192927A patent/NZ192927A/xx unknown
- 1980-02-20 LU LU82185A patent/LU82185A1/fr unknown
- 1980-02-26 FI FI800566A patent/FI66357C/fi not_active IP Right Cessation
- 1980-02-27 AR AR280106A patent/AR222691A1/es active
- 1980-02-29 PT PT70882A patent/PT70882A/pt unknown
- 1980-03-03 CH CH165080A patent/CH644368A5/fr not_active IP Right Cessation
- 1980-03-04 CA CA346,981A patent/CA1132561A/en not_active Expired
- 1980-03-04 NL NLAANVRAGE8001289,A patent/NL184833C/xx not_active IP Right Cessation
- 1980-03-07 AU AU56248/80A patent/AU533547B2/en not_active Ceased
- 1980-03-07 GB GB8007908A patent/GB2045756B/en not_active Expired
- 1980-03-07 NO NO800664A patent/NO154054C/no unknown
- 1980-03-07 IE IE477/80A patent/IE49547B1/en unknown
- 1980-03-07 SE SE8001812A patent/SE435180B/sv not_active IP Right Cessation
- 1980-03-09 EG EG131/80A patent/EG14282A/xx active
- 1980-03-10 DE DE3009071A patent/DE3009071C2/de not_active Expired
- 1980-03-10 OA OA57049A patent/OA06484A/xx unknown
- 1980-03-10 MX MX808702U patent/MX6218E/es unknown
- 1980-03-10 FR FR8005277A patent/FR2451191A1/fr active Granted
- 1980-03-10 JP JP2931280A patent/JPS55122768A/ja active Granted
- 1980-03-10 FR FR8005278A patent/FR2451370A1/fr active Granted
- 1980-03-10 DE DE3050999A patent/DE3050999C2/de not_active Expired
- 1980-04-30 DE DE19803016752 patent/DE3016752A1/de active Granted
1983
- 1983-04-28 SG SG226/83A patent/SG22683G/en unknown
- 1983-11-17 HK HK553/83A patent/HK55383A/xx unknown
1984
- 1984-12-30 MY MY200/84A patent/MY8400200A/xx unknown

Also Published As

Publication number	Publication date
FR2451191B1 (no)	1983-04-29
AU533547B2 (en)	1983-12-01
IN153791B (no)	1984-08-18
OA06484A (fr)	1981-07-31
NL184833C (nl)	1989-11-16
FI66357B (fi)	1984-06-29
DE3009071A1 (de)	1980-09-11
FR2451370B1 (no)	1983-05-13
GB2045756B (en)	1983-01-26
NO154054C (no)	1986-07-09
DE3050999C2 (de)	1986-08-14
FI66357C (fi)	1984-10-10
NO800664L (no)	1980-09-11
DE3016752C2 (no)	1987-06-25
MY8400200A (en)	1984-12-31
EG14282A (en)	1983-09-30
DE3050999A1 (no)	1985-08-14
BE881752A (fr)	1980-05-30
FI800566A (fi)	1980-09-11
JPS6126996B2 (no)	1986-06-23
IE49547B1 (en)	1985-10-30
DE3009071C2 (de)	1985-11-14
FR2451370A1 (fr)	1980-10-10
LU82185A1 (fr)	1980-06-06
NO154054B (no)	1986-04-01
JPS55122768A (en)	1980-09-20
PT70882A (en)	1980-03-01
DE3016752A1 (de)	1980-12-04
GB2045756A (en)	1980-11-05
SE8001812L (sv)	1980-09-11
SE435180B (sv)	1984-09-10
HK55383A (en)	1983-11-25
AU5624880A (en)	1980-09-18
SG22683G (en)	1983-12-16
NL184833B (nl)	1989-06-16
IE800477L (en)	1980-09-10
CA1132561A (en)	1982-09-28
NL8001289A (nl)	1980-09-12
CH644368A5 (en)	1984-07-31
NL184468B (nl)	1989-03-01
FR2451191A1 (fr)	1980-10-10
AR222691A1 (es)	1981-06-15
MX6218E (es)	1984-12-21

Publication	Publication Date	Title
IL60555A0 (en)	1980-09-16	Pharmaceutical compositions containing certain ureal derivatives
GB8315756D0 (en)	1983-07-13	Preparation of activated pharmaceutical compositions
NZ188320A (en)	1981-01-23	Thienothiazine derivatives preparation and pharmaceutical compositions
NZ193798A (en)	1983-11-18	3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
MY8700186A (en)	1987-12-31	3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them
NZ194421A (en)	1982-05-31	3-amino-sydnone-imines pharmaceutical compositions
DE3072103D1 (en)	1988-08-04	Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
NZ192927A (en)	1981-07-13	Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions
NZ190810A (en)	1981-10-19	1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
IL60376A0 (en)	1980-09-16	3-methyleneazetidine derivatives and pharmaceutical compositions containing them
NZ194784A (en)	1982-12-21	7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
NZ193344A (en)	1983-06-14	Pyran-4-one derivatives and pharmaceutical compositions
NZ193557A (en)	1982-03-09	4-phenylchroman derivatives intermediates and pharmaceutical compositions
NZ194490A (en)	1983-03-15	25-halocholest-5-ene-3 22-diol derivatives pharmaceutical compositions
PT72066A (en)	1980-12-01	Process for the preparation of novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof
IL58621A0 (en)	1980-02-29	Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
PH16220A (en)	1983-08-09	Pyrro-lidine derivatives and pharmaceutical compositions thereof
NZ193421A (en)	1981-11-19	Preparation of isopropylaminopyrimidine hydroxy derivatives pharmaceutical compositions
NZ187285A (en)	1982-03-23	Azacyclic derivatives of 6-amino-penam compounds and pharmaceutical compositions
IL60695A (en)	1983-11-30	Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them
IL61038A (en)	1983-12-30	15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
NZ188040A (en)	1981-07-13	1-phenylethanolamine derivatives pharmaceutical compositions
NZ194122A (en)	1982-05-25	Acylaminobenzoic acid derivatives and pharmaceutical compositions
NZ193533A (en)	1982-03-23	2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
PH15436A (en)	1983-01-18	4-amino-2-piperidinoquinazoline derivatives and pharmaceutical compositions thereof